Iotrolan liposomal

Drug Profile

Iotrolan liposomal

Alternative Names: TLC I 16

Latest Information Update: 16 Nov 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator The Liposome Company
  • Class Nonionic contrast media; Triiodobenzoic acids
  • Mechanism of Action Emission-computed tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Liver metastases

Most Recent Events

  • 16 Nov 1998 No development reported - Preclinical for Liver metastases diagnosis in USA (unspecified route)
  • 04 Sep 1996 Preclinical development for Liver metastases diagnosis in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top